Hansjorg Wyss
Direttore/Membro del Consiglio presso Avery Therapeutics, Inc.
Posizioni attive di Hansjorg Wyss
Società | Posizione | Inizio | Fine |
---|---|---|---|
Avery Therapeutics, Inc.
Avery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avery Therapeutics, Inc. engages in the development of tissue-engineered therapeutics to treat diseases and injuries to human muscle. Its product MyCardia™ is a tissue-engineered heart graft developed to treat heart failure. The company was founded by Steve Goldman and Jordan Lancaster in 2013 and is headquartered in Tucson, AZ. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Hansjorg Wyss
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Avery Therapeutics, Inc.
Avery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avery Therapeutics, Inc. engages in the development of tissue-engineered therapeutics to treat diseases and injuries to human muscle. Its product MyCardia™ is a tissue-engineered heart graft developed to treat heart failure. The company was founded by Steve Goldman and Jordan Lancaster in 2013 and is headquartered in Tucson, AZ. | Commercial Services |
- Borsa valori
- Insiders
- Hansjorg Wyss
- Esperienza